SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Microcap & Penny Stocks : TLT.v
TLT.V 0.245+2.1%4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ogi who wrote (1416)11/11/2019 12:06:02 PM
From: Underexposed  Read Replies (1) of 1460
 
TLT has stated Europe has been dropped in favour of just Canada and U.S..

I have not found a statement to what you said.... I have seen that Europe is last on the list to do testing.

Personally, as I have said in my past post, in my working life I was salesman for scientific instrumentation for Occupational Health and Safety (I did not say the last bit before) for over 15 years.

FDA approval is quite powerful but following a FDA approval protocol in Europe for testing probably does not carry any more weight to just getting that FDA approval in the USA. Europe probably has their own approval agency with probably a slightly different approval protocol. That and the fact that they don't have that CE certification on their equipment would slow them down.

I doubt that TLT dropped Europe as such.... they have enough on their plate with just getting the FDA Phase 2 approval which from what I have read could take up to 2 years to get.

the first step was getting the FDA Investigational New Drug (IND) Application approved. Now they applied for it on Oct 1/19 and FDA had 30 days to disapprove it if they see a problem with the application.

Well apparently there is no notice of disapproval after almost 8 weeks so I assume all is clear to go ahead with getting American sites for testing. Don't forget that TLT already discussed the testing protocol with FDA back in June... so this IND is just a formality IMHO.

So now begins the process of acquiring USA test sites which takes time.... look at how long it has taken to sign up 3 Canadian sites with more of those to come.

We just have to be patient.... After Phase 2 approval there is still Phases 3 and 4 to pass....

The sooner the U.S. gets underway the sooner TLT has access to 10x the possible trial participants and the more TLT becomes attractive to U.S. investors.
The sooner the U.S. gets underway the sooner TLT has access to 10x the possible trial participants and the more TLT becomes attractive to U.S. investors.

I too continue to be encouraged by Phase 1 trial results and can only imagine phase 2 trial will have minor procedural improvements that will benefit the process and we shall see if the double dose also improves results.

Agreed on all counts... the Science is what drives me... I like it and have held on for 4 years now with no return so far
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext